Valuation: Integra LifeSciences Holdings Corporation

Market Cap 1.28B 1.11B 1.03B 954M 1.8B 122B 1.83B 12.25B 4.8B 60.81B 4.82B 4.71B 204B P/E 2026 *
27.2x
P/E 2027 * 15.2x
Enterprise Value 2.77B 2.41B 2.24B 2.06B 3.88B 265B 3.95B 26.47B 10.36B 131B 10.41B 10.18B 442B EV / Sales 2026 *
1.66x
EV / Sales 2027 * 1.49x
Free-Float
72.36%
Yield 2026 *
-
Yield 2027 * -
1 day+2.64%
1 week-8.89%
Current month-5.85%
1 month-5.85%
3 months+60.44%
6 months+51.80%
Current year+36.15%
1 week 16.04
Extreme 16.04
20.49
1 month 16.04
Extreme 16.04
20.49
Current year 8.7
Extreme 8.7
20.49
1 year 8.7
Extreme 8.7
20.49
3 years 8.7
Extreme 8.7
46.09
5 years 8.7
Extreme 8.7
76.7
10 years 8.7
Extreme 8.7
77.4
Manager TitleAgeSince
Chief Executive Officer 64 01/05/2026
Director of Finance/CFO 54 28/06/2023
Chief Tech/Sci/R&D Officer - 17/02/2026
Director TitleAgeSince
Chairman 64 03/01/2012
Director/Board Member 81 01/01/1992
Director/Board Member 65 01/01/2006
Date Insider Type Main position Quantity % Market Cap.
3/7/26 Tax

Chief Financial Officer

-5,226 0.0067%
1/7/26 Free

Executive/Senior Manager

5,590 0.0072%
1/7/26 Free

Executive/Senior Manager

11,180 0.0144%
Change 5-day change 1-year change 3-year change Capi.($)
+2.73%-8.89%+36.70%-62.81% 1.28B
-2.37%+4.74%-17.91%-5.21% 187B
-2.46%+4.45%-6.53%-2.39% 112B
-1.99%+2.31%+6.96%+67.00% 61.99B
+0.32%-4.81%+25.21%+49.80% 48.52B
-1.95%+7.94%-9.04%-40.74% 46.4B
-1.93%+3.80% - - 33.89B
-1.20%+4.87%-17.01%-40.66% 28.99B
+0.16%-4.74%+35.88%-7.99% 23.75B
-1.78%+9.59%+0.69%+2.35% 22.89B
Average -1.08%+4.32%+6.11%-4.52% 56.66B
Weighted average by Cap. -1.87%+5.54%-4.54%+3.83%

Financials

2026 *2027 *
Net sales 1.67B 1.45B 1.35B 1.25B 2.35B 160B 2.39B 15.98B 6.26B 79.36B 6.29B 6.15B 267B 1.73B 1.5B 1.39B 1.28B 2.42B 165B 2.46B 16.47B 6.45B 81.8B 6.48B 6.34B 275B
Net income 42.03M 36.51M 33.9M 31.27M 58.9M 4.01B 59.96M 401M 157M 1.99B 158M 154M 6.7B 78.69M 68.35M 63.47M 58.54M 110M 7.51B 112M 751M 294M 3.73B 296M 289M 12.55B
Net Debt 1.49B 1.29B 1.2B 1.11B 2.09B 142B 2.12B 14.22B 5.57B 70.62B 5.59B 5.47B 237B 1.28B 1.12B 1.04B 956M 1.8B 123B 1.83B 12.27B 4.8B 60.92B 4.83B 4.72B 205B
Logo Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation is a global medical technology company. It manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.
Employees
4,427
Date Price Change Volume
31/07/26 US$16.96 +2.85% 1,073,043
29/07/26 US$16.49 -16.55% 2,550,972
28/07/26 US$19.76 +1.18% 1,166,340
27/07/26 US$19.53 -1.31% 1,015,193
24/07/26 US$19.79 +6.63% 901,081
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
16.49USD
Average target price
19.56USD
Spread / Average Target
+18.59%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IART Stock